Review and Clinical Perspectives for the Use of Infliximab in Ulcerative Colitis

Infliximab is a chimeric, monoclonal anti-tumour necrosis factor-alpha antibody. It has been previously demonstrated to be an effective treatment for patients with Crohn’s disease who do not achieve the desired response with conventional treatments. Although the etiology of ulcerative colitis (UC) d...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Remo Panaccione, Richard N Fedorak, Guy Aumais, Edmond-Jean Bernard, Charles N Bernstein, Alain Bitton, Ken Croitoru, Levinus A Dieleman, Robert Enns, Brian G Feagan, Denis Franchimont, Gordon R Greenberg, Anne-Marie Griffiths, John K Marshall, Pierre Pare, Sunil Patel, Robert Penner, Craig Render, Ernest Seidman, A Hillary Steinhart
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Wiley 2008-01-01
Serie:	Canadian Journal of Gastroenterology
Länkar:	http://dx.doi.org/10.1155/2008/493405
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!